6,613 results
·
48ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Neurologic Disease Risk Assessment Molecular Test
FDA classification
FDA Class 2
·Neurologic Disease Risk Assessment Molecular Test
System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen
Genetic Variant Detection And Health Risk Assessment System
FDA classification
FDA Class 2
·Genetic Variant Detection And Health Risk Assessment System
Spinal Muscular Atrophy Newborn Screening Test System
FDA classification
FDA Class 2
·Spinal Muscular Atrophy Newborn Screening Test System
Autosomal Recessive Carrier Screening Gene Mutation Detection System
FDA classification
FDA Class 2
·Autosomal Recessive Carrier Screening Gene Mutation Detection System
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Serpina1 Variant Detection System
FDA classification
FDA Class 2
·Serpina1 Variant Detection System
Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna
FDA classification
FDA Class 2
·Nucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna
System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony
FDA classification
FDA Class 2
·System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony
Cancer Predisposition Risk Assessment System
FDA classification
FDA Class 2
·Cancer Predisposition Risk Assessment System
Next Generation Sequencing Based Tumor Profiling Test
FDA classification
FDA Class 2
·Next Generation Sequencing Based Tumor Profiling Test
Whole Slide Imaging System
FDA classification
FDA Class 2
·Whole Slide Imaging System
Software Algorithm Device To Assist Users In Digital Pathology
FDA classification
FDA Class 2
·Software Algorithm Device To Assist Users In Digital Pathology
Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm
FDA classification
FDA Class 2
·Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm
Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System
FDA classification
FDA Class 2
·Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System
Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System
FDA classification
FDA Class 2
·Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System
High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids
FDA classification
FDA Class 2
·High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids
Cervical Intraepithelial Neoplasia (Cin) Test System
FDA classification
FDA Class 2
·Cervical Intraepithelial Neoplasia (Cin) Test System
Digital Pathology Display
FDA classification
FDA Class 2
·Digital Pathology Display